Summary of Key Points Core Viewpoint - On December 5, a total of 21 listed companies disclosed share reduction situations, while Meilixin announced plans for share buybacks ranging from 50 million to 100 million yuan [1][3]. Group 1: Share Buybacks - Meilixin's controlling shareholder plans to buy back shares worth between 50 million and 100 million yuan [2][4]. Group 2: Share Reductions - Several companies announced share reductions, including: - Saiwei Electronics: Directors and executives plan to reduce holdings by up to 152,200 shares [2][4]. - Tianci Materials: Directors and senior management plan to reduce holdings by up to 924,000 shares [2][4]. - Oujing Technology: Shareholder Wanzhao Huigu plans to reduce holdings by up to 3% [2][4]. - Yue Wannianqing: Hehe Investment reduced holdings by 2,183,900 shares from December 3 to 4 [2][4]. - New Media Shares: Shareholder Hengqin Hongtu Rongyao plans to reduce holdings by up to 0.11% [2][4]. - Others include Sai Lisi, Quanxin Hao, Mingxin Xuteng, Dongxing Medical, Aiyu Shares, and more, with various percentages and share counts disclosed [2][4].

Core Viewpoint - Dongxing Medical (301290.SZ) announced that shareholder Jiang Shihua, who holds 5,070,000 shares (5.0612% of total share capital), plans to reduce his holdings by up to 986,806 shares (0.9851% of total share capital) within a specified timeframe [1] Summary by Relevant Sections - **Shareholder Information** - Jiang Shihua holds 5,070,000 shares, representing 5.0612% of the company's total share capital [1] - After excluding shares in the company's repurchase account, his stake is 5.1378% [1] - **Reduction Plan** - The planned reduction will occur within two months, from December 29, 2025, to February 28, 2026 [1] - The reduction will be executed through centralized bidding or block trading [1] - The maximum number of shares to be reduced is 986,806, which is 0.9851% of the total share capital and 1.0000% when excluding repurchased shares [1]

Core Viewpoint - Dongxing Medical (301290.SZ) announced that shareholder Jiang Shihua plans to reduce his stake in the company by up to 986,800 shares, representing no more than 0.9851% of the total share capital, within a two-month period from December 29, 2025, to February 28, 2026, through centralized bidding or block trading [1] Summary by Category - Shareholder Action - Jiang Shihua intends to reduce his holdings by a maximum of 986,800 shares [1] - The reduction will account for up to 0.9851% of the company's total share capital [1] - Excluding shares in the company's repurchase account, the reduction represents up to 1.0000% of the adjusted total share capital [1]

Core Viewpoint - Dongxing Medical (301290.SZ) announced that shareholder Jiang Shihua plans to reduce his stake in the company by up to 986,800 shares, which represents no more than 0.9851% of the total share capital, within a two-month period starting from December 29, 2025, to February 28, 2026 [1] Summary by Relevant Categories Shareholder Actions - Jiang Shihua intends to reduce his holdings through centralized bidding or block trading methods [1] - The maximum number of shares to be sold is capped at 986,800, which is equivalent to no more than 1.0000% of the total share capital after excluding shares held in the company's repurchase account [1]

Core Viewpoint - Dongxing Medical announced that shareholder Jiang Shihua, holding 5.0612% of shares, plans to reduce holdings by up to 986,800 shares between December 29, 2025, and February 28, 2026, due to personal funding needs [1] Summary by Relevant Sections - **Shareholder Reduction Plan** - Jiang Shihua intends to reduce holdings through centralized bidding or block trading [1] - The reduction will not exceed 0.9851% of the company's total share capital [1] - After excluding shares in the company's repurchase account, the reduction will not exceed 1.0000% of the total share capital [1]

Company Information - Dongxing Medical (SZ 301290) announced on December 5 that shareholder Jiang Shihua plans to reduce his stake by up to approximately 990,000 shares within two months from December 29, 2025, to February 28, 2026, representing no more than 0.9851% of the total share capital, or less than 1% when excluding shares in the company's repurchase account [1][1][1] - As of the report, Dongxing Medical has a market capitalization of 2.6 billion yuan [1][1][1] Industry Overview - For the first half of 2025, Dongxing Medical's revenue composition is as follows: the medical device industry accounts for 82.23%, while other industries make up 17.77% [1][1][1]

Core Viewpoint - Dongxing Medical announced that shareholder Jiang Shihua, holding 5.0612% of shares, plans to reduce holdings by up to 986,800 shares between December 29, 2025, and February 28, 2026, due to personal funding needs [1] Summary by Relevant Sections - **Shareholder Reduction Plan** - Jiang Shihua intends to reduce holdings through centralized bidding or block trading [1] - The reduction will not exceed 0.9851% of the company's total share capital [1] - After excluding shares in the company's repurchase account, the reduction will not exceed 1.0000% of the total share capital [1]

Core Viewpoint - Jiang Shihua, a shareholder holding more than 5% of Dongxing Medical, plans to reduce his shareholding by up to 986,806 shares, which represents no more than 0.9851% of the company's total share capital, within a two-month period starting from December 29, 2025, to February 28, 2026 [1] Summary by Categories Shareholding Reduction - Jiang Shihua intends to reduce his holdings through centralized bidding or block trading, with the maximum number of shares to be reduced being 986,806 [1] - The reduction will not lead to a change in the company's control, as Jiang Shihua is not a controlling shareholder or actual controller [1] Impact on Company - The share reduction is attributed to personal funding needs and will not affect the company's ongoing operations [1] - The shareholding percentage will be adjusted if there are changes in the number of shares due to stock dividends, capital reserve transfers, or share buybacks during the reduction period [1]

证券代码：301290 证券简称：东星医疗 公告编号：2025-055 江苏东星智慧医疗科技股份有限公司 关于持股 5%以上股东减持股份的预披露公告 持股 5%以上股东江世华先生保证向本公司提供的信息内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 1、持有江苏东星智慧医疗科技股份有限公司（以下简称"公司"）股份 5,070,000 股（占公司总股本的 5.0612%，占剔除公司回购专户中股份总数后总股 本的 5.1378%）的股东江世华先生，计划自本公告披露之日起十五个交易日后的 2 个月内（即 2025 年 12 月 29 日至 2026 年 2 月 28 日）通过集中竞价或大宗交 易方式减持公司股份不超过 986,806 股（占公司总股本比例不超过 0.9851%，占 剔除公司回购专户中股份总数后总股本比例不超过 1.0000%）。 2、若在减持期间公司发生送股、资本公积金转增股本、回购股份注销等股 份变动事项，上述减持股份数量将相应调整。 2、减持原因：个人资金需求 3、减持股份来源：公司首次公开发行股票前已发 ...

Group 1 - The company, Dongxing Medical, announced plans to utilize up to RMB 670 million of idle raised funds (including oversubscription funds) and up to RMB 600 million of idle self-owned funds for cash management [2] - The announced amounts and usage period can be rolled over within 12 months from the date of approval by the company's shareholders' meeting [2]